Allecra and Acino Ink Pact for Allecra's Novel Antibiotic Exblifep

Allecra Therapeutics and Acino declared the signing of a licensing agreement in which Acino acquire privileges to popularize Allecra's anti-microbial medication Exblifep (cefepime/enmetazobactam) within the Republic of South Africa and the member...

GSK's Omjjara Secures Japanese Nod For Treatment of Myelofibrosis

GSK plc, a biotechnology company, reported that Japan's Ministry of Health, Labour and Welfare (MHLW) has endorsed Omjjara (momelotinib) for the treatment of myelofibrosis. Omjjara is an oral, once-daily inhibitor of JAK1/JAK2 and the activin A...

Roche Unveils New Analytical Units For Cobas pro Integrated Solutions

Roche, a leading biotechnology firm, declared the availability of its new analytical units, the cobas c 703 and cobas ISE neo, for the cobas pro integrated solutions, in nations accepting the CE mark. The cobas c 703 and cobas ISE neo logical...

ISTH Releases Clinical Practice Guideline For Haemophilia Treatment

The International Society on Thrombosis and Haemostasis (ISTH), the most prominent international professional medical-scientific organization committed to improving the understanding, prevention, diagnosis, and treatment of thrombotic and...

Melodia Therapeutics and Alivexis Ink Pact For Cathepsin C Inhibitor

Alivexis, Inc. furthermore, Melodia Therapeutics AG, an organization set up by Forty51 Endeavors, declared that they have forayed into an exclusive license agreement for the overall development, assembling, and commercialization of Alivexis...

Basilea Pharma and Glioblastoma Partner For Oncology Drug Candidate

Basilea Pharmaceutica Ltd., a commercial-stage biopharmaceutical firm with headquarters in Switzerland dedicated to treating patients with severe bacterial and fungal infections, declared that it has forayed into an asset purchase agreement...

Sanofi and Biovac Lead Polio Vaccine Manufacturing Capabilities

Sanofi and Biovac, a Cape Town, South Africa-based biopharmaceutical business, have announced a local manufacturing agreement to produce inactivated polio vaccines (IPV) in Africa. This partnership aims to enable regional manufacturing of polio...

Sun Pharma and Takeda Ink Pact To Market Gastrointestinal Drug

Sun Pharmaceutical Industries Limited stated that it has signed a non-exclusive patent licensing deal with Takeda Pharmaceutical Company Limited (Takeda) to market vonoprazan tablets 10 mg and 20 mg in India under the brand name "Voltapraz"...

Roche Introduces in-situ Hybridisation Test To Help Pathologists

Roche, a swiss based healthcare firm, declared the launch of the first clinically approved, highly sensitivity in-situ hybridisation (ISH) test, the VENTANA Kappa and Lambda Dual ISH mRNA Probe Cocktail assay in nations embracing the CE Mark...

Aethlon Medical Receives HREC's Nod for Hemopurifier Cancer Trial

Aethlon Medical, Inc., a medical therapeutic company dedicated to creating products to treat cancer and life-threatening infectious illnesses, declared that the Human Research Ethics Committee (HREC) of the Central Adelaide Local Health Network...

© 2025 India Pharma Outlook. All Rights Reserved.